Cite
MLA Citation
Hiroaki Sakamoto et al.. “Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib.” Cancer reports, vol. 4, no. 6, 2021, p. n/a. http://access.bl.uk/ark:/81055/vdc_100148077519.0x000006